
Bioneex operates as an AI-powered biopharma matchmaking platform, connecting drug development companies with strategic partners and venture capital investors. The platform facilitates licensing, co-development partnerships, and investment deals by enabling biotech and biopharma companies, along with venture capital firms, to connect directly. Bioneex serves over 300 drug development companies, biopharma companies, and investors, facilitating more than 10 matchmaking sessions weekly. For drug development companies (Providers), Bioneex aids in business development outreach by allowing them to list drug candidates and technologies, receive profile improvements, and connect with suitable Seekers for potential deals. For biopharma partners and venture capital investors (Seekers), the platform simplifies the search and evaluation of drug candidates and technologies through AI-powered search, direct connections with Providers, and automated deal flow updates.

Bioneex operates as an AI-powered biopharma matchmaking platform, connecting drug development companies with strategic partners and venture capital investors. The platform facilitates licensing, co-development partnerships, and investment deals by enabling biotech and biopharma companies, along with venture capital firms, to connect directly. Bioneex serves over 300 drug development companies, biopharma companies, and investors, facilitating more than 10 matchmaking sessions weekly. For drug development companies (Providers), Bioneex aids in business development outreach by allowing them to list drug candidates and technologies, receive profile improvements, and connect with suitable Seekers for potential deals. For biopharma partners and venture capital investors (Seekers), the platform simplifies the search and evaluation of drug candidates and technologies through AI-powered search, direct connections with Providers, and automated deal flow updates.
Business: AI-powered biopharma R&D matchmaking marketplace connecting drug developers, partners, and investors
Scale: Serves 300+ biotech/biopharma companies and investors
Funding: Closed a $0.5M seed round in Feb 2024; launched a follow-on $6M raise
Headquarters: Syracuse, NY with a European subsidiary in Berlin
Biopharma R&D business development and dealmaking
2020
Biotechnology
$500,000
Seed round described as oversubscribed; company announced a subsequent $6M fundraising round after the seed close.
“BANA Angels; seed round led by biopharma industry executives (including former Pfizer and Amgen executives)”